News & Analysis as of

Life Sciences Private Equity Private Equity Funds

Brownstein Hyatt Farber Schreck

As Election Looms, Headwinds Brewing for Private Equity Health Care Dealmaking

As this fall’s election approaches, headwinds have been brewing in DC and state legislatures for private equity health care dealmaking, many of them with bipartisan support. While a key Senate committee scrutinized patient...more

Bass, Berry & Sims PLC

BBS Connect April 2024

Bass, Berry & Sims PLC on

Bass, Berry & Sims’ Healthcare Private Equity Team is pleased to share with you our first installment of the BBS Connect Newsletter for 2024. This publication is an extension of our OP Talent Network (OPT-N), which connects...more

Polsinelli

California’s AB 3129 Continues National Trend of Scrutinizing Private Equity Investments in the Health Care Industry

Polsinelli on

The California legislature is considering a bill that could severely impact the ability for private equity companies and hedge funds to operate in the California health care industry. AB 3129, introduced by Assembly Member...more

McGuireWoods LLP

[Event] 20th Annual Healthcare Private Equity and Finance Conference - May 8th - 9th, Chicago, IL

McGuireWoods LLP on

Mark your calendar for the 2024 McGuireWoods Healthcare Private Equity and Finance Conference, and help us celebrate 20 years of bringing healthcare industry leaders together. This premier two-day healthcare...more

McDermott Will & Emery

[Event] European Health and Life Sciences Symposium 2023 - November 7th, Paris, France

McDermott Will & Emery on

We can't wait to see you in Paris at our second annual symposium. You'll meet with senior executives in the health, life sciences and private equity industries to identify new investment opportunities and position your...more

Wilson Sonsini Goodrich & Rosati

2023 Mid-Year Technology and Life Sciences PIPE and RDO Report

Wilson Sonsini Goodrich & Rosati’s 2023 Mid-Year Technology and Life Sciences PIPE and RDO Report presents analysis related to 87 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by...more

McDermott Will & Emery

[Event] HPE Europe 2023 - September 21st, London, United Kingdom

McDermott Will & Emery on

HPE Europe is back! Join the biggest names in healthcare, life sciences and private equity for an unforgettable day of thought-provoking discussions, cutting-edge insights and valuable networking opportunities at the...more

Wilson Sonsini Goodrich & Rosati

2022 Technology and Life Sciences PIPE Report

In this inaugural issue of the 2022 Technology and Life Sciences PIPE Report, we present analysis related to 108 private investments in public equity (PIPEs) by U.S.-based technology and life sciences companies between...more

Troutman Pepper

What We're Seeing – 2022 Dealmaking Outlook

Troutman Pepper on

The Rearview Mirror - Robust multiples and fear that the Biden administration might succeed in passing tax laws resulted in 2021 being one of the busiest years ever in the private equity space. Within the capital markets,...more

Bass, Berry & Sims PLC

Healthcare Transactions Q2 2021

Bass, Berry & Sims PLC on

Following a record-breaking first quarter, merger and acquisition (M&A) activity within the healthcare industry kept pace during the second quarter of 2021, showing no signs of slowing. Although the volume of deal activity...more

McDermott Will & Emery

[Virtual Event] HPE Europe 2021 - June 23rd - 24th, 12:20 pm - 1:30 pm GMT

This year, recognising that as we are still unable to meet in person, our HPE Europe EVENT will be going ahead with two exclusive, virtual extended lunch time sessions. We will be joined by investors including key players...more

Bass, Berry & Sims PLC

Looking through the Scope: 5 Key Diligence Considerations When Buying a GI Practice

Bass, Berry & Sims PLC on

Private equity investors’ interest in gastroenterology (GI) practices continues to remain strong, despite some headwinds that GI practices have experienced as a result of the COVID-19 pandemic and further investment in this...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: Frazier Healthcare Partners Acquires Stake in CSafe Global From THL

McGuireWoods LLP on

Frazier Healthcare Partners has acquired a 50% stake in CSafe Global from Thomas H. Lee Partners (THL), according to a news release. CSafe Global, based in Dayton, Ohio, is a provider of cold chain shipping solutions to...more

McGuireWoods LLP

Petrichor Closes Fund With $410 Million

McGuireWoods LLP on

Petrichor Healthcare Capital Management has announced it has closed Petrichor Opportunities Fund I. The firm reported that the new fund was oversubscribed with $410 million in commitments....more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: Northlane Capital Invests in VMG Health

McGuireWoods LLP on

Northlane Capital Partners (NCP) has announced it has invested in VMG Health....more

McDermott Will & Emery

COVID-19 – Contingency Planning Checklist for Private Equity Portfolio Companies

McDermott Will & Emery on

Following the wider outbreak of the coronavirus (COVID-19) around the world, radical—and sometimes controversial—actions have been and are further expected to be taken by national, federal and local governments and...more

McGuireWoods LLP

NovaQuest Closes New PE Fund With $275 Million

McGuireWoods LLP on

NovaQuest Private Equity has reached its hard cap of $275 million in capital commitments for a new private equity (PE) fund, according to a news release....more

McGuireWoods LLP

Enhanced Healthcare Partners Closes New Fund With $300 Million

McGuireWoods LLP on

Enhanced Healthcare Partners (EHP) has announced the closing of a new fund, with $300 million of committed capital and access to $600 million in total equity....more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: CapStreet Recaps Surgical Notes

McGuireWoods LLP on

The CapStreet Group has announced it has completed a majority recapitalization of Surgical Notes. Surgical Notes, headquartered in Dallas, is a healthcare technology company that develops and provides revenue cycle...more

McGuireWoods LLP

Investor Interest in Orthopedics – 5 Key Points

McGuireWoods LLP on

Orthopedic practices offer a compelling opportunity for private equity investment and are likely to see significant interest from funds in the near future, according to experts who spoke on a panel titled “Investor Interest...more

McGuireWoods LLP

Investments in Provider Support Technology: Mobile Apps, Revenue Cycle Businesses, and Similar Investments – 5 Key Points

McGuireWoods LLP on

The next in our series of posts sharing key takeaways from panels at the Healthcare & Life Sciences Private Equity and Lending Conference focuses on investing in and implementing technology. It is authored by Kayla McCann...more

McGuireWoods LLP

Current Issues in the Oncology and Infusion Therapy Space: Five Key Points

McGuireWoods LLP on

The next in our series of posts sharing key takeaways from panels at the Healthcare & Life Sciences Private Equity and Lending Conference focuses on trends and developments in oncology and infusion therapy. It is authored by...more

McGuireWoods LLP

Key Takeaways From the 2019 Healthcare and Life Sciences Private Equity and Finance Conference

McGuireWoods LLP on

McGuireWoods recently held its 16th Annual Healthcare and Life Sciences Private Equity and Finance Conference at the Four Seasons Hotel in Chicago. The premier two-day conference, held Feb. 20-21, provided content-rich...more

McGuireWoods LLP

15 Private Equity in Healthcare – An Updated Review of Selected Niche Investment Areas

McGuireWoods LLP on

Private equity investment in healthcare has continued to grow considerably from when we examined various niche investment areas on April 11, 2016, in the article titled “Private Equity in Healthcare – A Review of 15 Niche...more

24 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide